Williams R Sanders
SEC CIK 1375347 · EDGAR
BoughtSold
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Williams R Sanders made no open-market trades at LH in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | Williams R Sanders | Dir | M - OptEx | — | +947 | 8,120 | +13% | — |
| 2023-05-23 | 2023-05-19 | AMGN | Amgen | Williams R Sanders | Dir | A - Grant | $0.00 | +939 | 6,240 | +18% | $0 | |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | Williams R Sanders | Dir | M - OptEx | — | +742 | 7,173 | +12% | — |
| 2022-08-22 | 2022-08-22 | AMGN | Amgen | Williams R Sanders | Dir | S - Sale | $249.96 | -200 | 5,301 | -4% | -$50.0K | |
| 2022-05-23 | 2022-05-23 | AMGN | Amgen | Williams R Sanders | Dir | S - Sale | $250.00 | -600 | 5,501 | -10% | -$150.0K | |
| 2022-05-19 | 2022-05-17 | AMGN | Amgen | Williams R Sanders | Dir | A - Grant | $0.00 | +855 | 6,101 | +16% | $0 | |
| 2022-03-29 | 2022-03-25 | LH | Labcorp | Williams R Sanders | Dir | S - Sale | $272.98 | -572 | 6,431 | -8% | -$156.1K | |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Williams R Sanders | Dir | M - OptEx | — | +771 | 7,003 | +12% | — |
Purchase Sale Sale after option exercise All abbreviations